Use of (x-aminomethyl-3,4-dichlorobenzyl) thioacetamide derivatives for inhibiting dopamine reutake and new compounds for this use
US5795915A · kind A · utility
1Cited by
0References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 17, 1996 |
| Grant date | Aug 18, 1998 |
| Priority date | — |
| Expiry date | May 17, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of a compound selected from: PA1 .alpha.-(tert-butylaminomethyl)-3,4-dichlorobenzyl!thioacetamide and its laevorotatory isomer, PA1 .alpha.-(tert-amylaminomethyl)-3,4-dichlorobenzyl!thioacetamide and its isomers, PA1 .alpha.-(1-adamantylaminomethyl)3,4-dichlorobenzyl!thioacetamide and its isomers, as well as the addition salts of these compounds with pharmaceutically acceptable acids, for inhibiting dopamine reuptake.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.